4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Knight Therapeutics Inc. (GUD) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Montreal, Canada with about 830 employees. Its market capitalization is roughly C$1 billion. In the fiscal year ended 2025-12-31, GUD reported C$450M in revenue and (C$5M) in net income.
Knight Therapeutics Inc. focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
Interactive charts & full statements → Open the GUD valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | C$450M | C$371M | C$328M | C$294M | — |
| Gross Profit | C$200M | C$174M | C$153M | C$138M | — |
| Operating Income (EBIT) | (C$2M) | C$7M | C$6M | (C$17M) | — |
| Net Income | (C$5M) | C$4M | (C$17M) | (C$30M) | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | C$144M | C$148M | C$133M | C$107M | C$88M |
| Gross Profit | C$70M | C$69M | C$65M | C$45M | C$35M |
| Operating Income (EBIT) | C$9M | C$11M | C$6M | (C$4M) | (C$6M) |
| Net Income | (C$3M) | C$13M | C$9M | (C$13M) | C$2M |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | C$0M | C$0M | C$0M | C$0M | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | C$0M | C$0M | C$0M | C$0M | C$0M |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | C$1.0B | C$964M | C$946M | C$1.1B | — |
| Total Liabilities | C$279M | C$169M | C$199M | C$229M | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GUD viewer.
About TickerBase · Data methodology & sources · Privacy · Terms